It's primarily because a lot of the products under development in the pipeline right now involve modifying the plant's natural characteristics. So you're basically pushing it in a particular direction using its internal machinery, as opposed to the products out there right now, into which what I would call an alien gene has been dropped. It does its job. It's sort of like a spaceship out there. But when you start to push the plant to become more cold resistant or to enhance its resistance to a fungal pathogen, you're really stretching the internal machinery. I don't think the tools we've been using until now to assess those plants are going to be as informative as they should be.
On the other hand, the bottom line in the assessment process is whether this thing grows, looks, behaves, and tastes like canola. As far as we can tell, it does. So that's probably still the criterion they're going to use. But I would argue that these more subtle changes that are being contemplated right now will be very hard for the regulators to deal with.